Client Result
Orrick Advises COVA Acquisition on $3.82 Billion SPAC Merger with ECARX
1 minute read | December.20.2022

1 minute read | December.20.2022
1 minute read | November.03.2022
May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
April.13.2022
September.10.2021
September.02.2021
August.25.2021
June.04.2020